Skip to main content
. 2021 Apr 13;12:646874. doi: 10.3389/fimmu.2021.646874

Figure 3.

Figure 3

Overview of the model design. Pathway-model was constructed and trained by 70% Hellmann cohort. Then, the predictor was tested in one validation cohort (the remaining 30% of Hellman cohort) and two independently testing cohorts (100% of Rizvi cohort and 100% of GloriousMed cohort).